Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2015-09-07 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于召开2015年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2015 second extraordinary general meeting (临时股东大会) of Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It includes information about the meeting date, voting methods (both onsite and online), agenda items for shareholder approval, registration procedures, and voting instructions. The content focuses on notifying shareholders about the meeting and providing procedural details for participation and voting on specific proposals, including a non-public stock issuance plan. There is no financial data, earnings information, or management discussion of results. The document is not a report itself but an announcement about a shareholder meeting and its agenda. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2015-09-07 Chinese
湖南盛丰林木资产涉及的土地租赁明细表
Regulatory Filings Classification · 85% confidence The document consists of detailed tables listing land lease details including contract area, lease term, annual rent, and remarks. There is no indication of financial statements, management commentary, regulatory announcements, or any corporate governance or shareholder meeting information. The content is purely operational data related to land leasing assets. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any governance or legal filings. It is a detailed asset-related data report, but not a financial report or announcement. Given the nature of the content, the best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit other categories.
2015-08-26 Chinese
湖南盛丰生态农林有限公司审计报告
Audit Report / Information Classification · 95% confidence The document is titled '审计报告' (Audit Report) for 湖南盛丰生态农林有限公司, with a report number and date in 2015. It includes detailed financial statements such as balance sheets, income statements, cash flow statements, and statements of changes in equity for the period from January 1, 2014, to March 31, 2015. The text contains the auditor's responsibilities, management's responsibilities, and the auditor's opinion, which are typical components of an audit report. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It is not an annual report (10-K) because it covers a period ending March 31, 2015, and includes an audit opinion specifically labeled as an audit report. It is not a certification or attestation letter but a full audit report with financial statements and notes. Therefore, the document fits the category of an Audit Report / Information (AR). Q1 2015
2015-08-26 Chinese
拟收购江西高峰生态农林开发有限公司65%股权项目资产评估报告
Capital/Financing Update Classification · 95% confidence The document is an asset appraisal report for a proposed acquisition of 65% equity in Jiangxi Gaofeng Ecological Forestry Development Co., Ltd. by Jiangsu Sihuan Biological Co., Ltd. It is titled as an "资产评估报告" (Asset Evaluation Report) and contains detailed valuation methods, asset and liability breakdowns, legal and regulatory references, and valuation conclusions. The report is prepared by a professional asset appraisal firm and includes comprehensive financial and asset valuation data as of a specific valuation date (March 31, 2015). This is a standalone asset appraisal report related to a capital transaction (acquisition). It is not an annual or interim financial report, nor an earnings release or management discussion. It is not a regulatory announcement or a proxy statement. The document is a detailed valuation report supporting a financing/acquisition transaction. According to the filing definitions, this fits best under "Capital/Financing Update (CAP)" as it provides updates on company fundraising, financing activities, or capital structure changes, specifically an acquisition. Therefore, the correct classification is CAP with high confidence.
2015-08-26 Chinese
公司与陈建国签署之附条件生效的股份认购合同
Capital/Financing Update Classification · 95% confidence The document is a detailed contract titled '附条件生效的股份认购合同' (Conditional Effective Share Subscription Agreement) between 江苏四环生物股份有限公司 and an individual named 陈建国. It outlines terms for a non-public issuance of shares, including subscription price, payment terms, lock-up period, representations and warranties, confidentiality, breach liabilities, and legal jurisdiction. The document is a legal contract related to a private placement or non-public share issuance, not a report or announcement of financial results or corporate governance changes. It does not contain financial statements, audit opinions, or meeting materials. It is not a regulatory filing announcing a report, nor a certification or voting result. The content is focused on capital raising through a private share subscription agreement, which fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters but contains substantive contractual details rather than a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is CAP with high confidence.
2015-08-26 Chinese
公司与申万宏源证券有限公司签署之附条件生效的股份认购合同
Capital/Financing Update Classification · 95% confidence The document is a detailed contract titled '附条件生效的股份认购合同' (Conditional Effective Share Subscription Agreement) between Jiangsu Sihuan Bio and Shenwan Hongyuan Securities Co., Ltd. It outlines terms for a non-public issuance of shares, subscription price, payment terms, lock-up period, representations and warranties, confidentiality, breach liabilities, applicable law, dispute resolution, contract modifications, and conditions for effectiveness. The content is a legal agreement related to a capital raising transaction involving share subscription and issuance. It is not a report, announcement of voting results, nor a regulatory filing or certification. It is a contract document related to financing activity, specifically a non-public share issuance subscription agreement. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 3668 characters, which is consistent with a contract rather than a full report or announcement. Confidence is high given the clear nature of the document as a share subscription contract.
2015-08-26 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.